Introduction {#sec1}
============

Early life stress (ELS), including physical, sexual, and emotional forms of abuse and neglect experienced by the developing child ([@ref10]), has been linked to a host of physical and psychological sequelae into adulthood ([@ref11]; [@ref28]; [@ref49]; [@ref59]). Such adverse experiences are surprisingly common, according to a large-scale epidemiological study on adverse childhood events, which reports that approximately 65% of people in the United States experienced at least one, and 12.5% experienced as many as four, adverse early life events ([@ref49]). Given these statistics, a deeper understanding of the pathophysiology of ELS could produce better long-term prognosticators of adverse sequelae for vulnerable individuals, and promote the development of patient-centered interventions with specific strategies to mitigate the ill effects of ELS.

To elucidate the connection between ELS and negative health outcomes, research examined putative physiological mediators, including the sympathetic nervous system (SNS), the hypothalamic pituitary adrenal (HPA) axis, and cytokines linked to inflammation ([@ref45]; [@ref58]). Dysregulation of these systems has been associated with a host of disorders in and of themselves ([@ref14]; [@ref15]; [@ref40]). In this review, we will examine the connections between ELS and these physiological pathways in both human adults and mature non-human animals. We will additionally consider the potential role of candidate gene polymorphisms and DNA methylation in genes linked to the stress response and to mood disorders as moderators of the ELS-negative health outcome relationship. Finally, we will offer recommendations for a growing field examining the effects of ELS into adulthood.

An Overview of Acute Stress Physiology and Inflammatory Markers {#sec2}
===============================================================

Stress promotes physiological responses across several different systems, most prominently the SNS, HPA axis, and immune system, which are heavily intertwined ([@ref12]). For instance, brain regions processing sensory and psychological stressors activate preganglionic neurons in brain stem and spinal cord to activate the peripheral SNS. This then prepares the body to "fight or flee" by releasing catecholamines such as epinephrine and norepinephrine to increase heart rate and blood pressure. In parallel, stress activates the HPA axis, leading to the release of corticotropin-releasing factor (CRF) by the hypothalamus, followed by the release of adrenocorticotropin-releasing hormone (ACTH) onto CRH-R1 receptors from the pituitary, and subsequent release of glucocorticoids (including cortisol in humans and corticosterone in animals) from the adrenal glands ([@ref44]). Both activation of the SNS and HPA axis are correlated with inflammatory markers, including tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and interleukin-6 (IL-6) ([@ref13]; [@ref65]; [@ref56]).

For the purposes of this review, we will focus on these and similar markers to assess the impact of ELS on stress physiology. [Figure 1](#fig1){ref-type="fig"} presents an overview of these markers, their relationship to one another, and their potential changes in the presence of stress.

![ELS may impact gene methylation. ELS, working in conjunction with genetics, is associated with increased heart rate and inflammation. Evidence is inconsistent on the effects of catecholamines and signaling pathways associated with the HPA axis. The SNS, HPA axis, and immune system exhibit reciprocal effects on one another. Images adapted from open license image site [smart.servier.com](http://smart.servier.com).](fpsyg-10-01668-g001){#fig1}

Early Life Stress, Sympathetic Nervous System, Hypothalamic-Pituitary-Adrenal Axis, and Inflammation in Humans {#sec3}
==============================================================================================================

Several studies have found a relationship between ELS and cardiovascular/HPA axis effects. For instance, [@ref19] saw a direct relationship between ELS and ischemic heart disease later in life, although this was partially mediated by presence of additional psychological risk variables such as anger levels and depressed affect. [@ref27] observed that an increase in the number of ELS events in healthy adult participants was associated with higher resting and activated heart rates. Similarly, [@ref32] reported elevated heart rate in response to the Trier Social Stress Test (TSST) in a group of depressed women who had experienced sexual and/or physical abuse early in life, compared to non-depressed women without ELS. Within the same group, depressed ELS women displayed heightened cortisol reactivity and dysregulated ACTH (the latter was seen in women with ELS regardless of depression status; [@ref32]). In line with a heightened cortisol response, individuals in a community-based sample with ELS and a psychiatric history displayed poorer recovery and exhibited significantly stronger cortisol reactivity to a cognitive stress task, compared to the non-ELS group ([@ref29]). Yet, others reported *diminished* cortisol associated with ELS. For instance, women who had experienced ELS showed lower baseline cortisol levels preceding a corticotropin-releasing factor (CRF) stimulation test (a bolus of CRF given in the afternoon), but produced a similar post-stressor cortisol response, compared to non-ELS controls ([@ref31]). ELS was also associated with blunted cortisol in another common HPA outcome measure, the cortisol awakening response, in a different study ([@ref41]). Given the conflicting literature, we conducted a comprehensive meta-analysis, in which we found no significant association between early life stress and cortisol ([@ref25]). We did, however, note strong heterogeneity across studies, suggesting that "type of stressor" may be an important moderator of subsequent cortisol physiology. For instance, experiencing abuse was associated with increased cortisol awakening response levels, suggesting that some forms of trauma may be more severe and hence have a more profound and lasting impact on physiology.

ELS is also associated with increased inflammation, both basally and in response to acute stress. One longitudinal study that followed participants since childhood, demonstrated a link between ELS and high-sensitivity C-reactive protein (hsCRP) levels ([@ref17]). ELS was also associated with heightened IL-6 in response to the TSST ([@ref7]) and with heightened IL-1β, IL-12, and TNF-α levels ([@ref41]) in healthy community samples. In a patient cohort of depressed individuals, there was no significant main effect between ELS and inflammatory markers; however, depressed patients displayed greater ELS and an increase in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and IL-6 in response to the TSST ([@ref55]).

In addition to ELS being linked to the SNS, HPA axis, and immune system, these systems have been shown to influence one another. For instance, [@ref24] proposed that increased sympathetic activity and dysregulated cortisol attributed to ELS may persist to low-grade inflammation over time. The "neuro-immune network" hypothesis by [@ref53] puts forth the notion that ELS strengthens cortico-amygdala neural circuitry, thus "priming" and responding to heightened SNS, HPA axis, and immune function over time. Taken together, these findings suggest that ELS, at least in certain groups and under certain conditions, has a potent effect on mediating pathways related to the cardiovascular system/HPA axis and markers of inflammation.

Early Life Stress, The Hypothalamic-Pituitary-Adrenal Axis, and Inflammation in Animals {#sec4}
=======================================================================================

In addition to studying the effects of ELS on health in human subjects, results from animal studies may offer helpful insights given the greater ability to manipulate experimental conditions and the simplified nature conditions surrounding ELS relative to human studies. Overall, experimental studies conducted in animal models of ELS tend to concur with human data suggesting heightened reactivity following ELS. For instance, one study found that rats who as pups had experienced maternal separation for either 15 or 180 min per day displayed higher levels of neuropeptide-y (a highly prevalent peptide associated with the CNS) than non-handled controls ([@ref35]), mirroring greater CNS reactivity we often see in human studies of ELS. In the same study, neuropeptide-y/CRF ratios were significantly lower in the maternal separation groups and the effect was dose dependent, such that more maternal separation was associated with lower ratios ([@ref35]); greater neuropeptide-y has been seen as protective in depression-like behavior in rats ([@ref64]), therefore a lower ratio represents a concern for increased rates of depression-like behavior in the presence of ELS. Other maternal separation studies reported elevated heart rate and inflammatory responses to a physiological stressor ([@ref42]), as well as elevated corticosterone, TNF-α, and IFN-γ levels, and increased production of anxiety-like behaviors ([@ref54]) in maternally deprived rats, compared to controls. In mice, ELS has also been linked with heightened basal corticosterone ([@ref500]). These findings bolster concerns of up-regulation of physiological response, similar to that seen in human studies.

Yet, as with the human literature, reports on the impact of ELS on physiology are not always consistent. For instance, social isolation in early development was associated with *lower* corticosterone levels in a recovery period following restraint-stress exposure in adult rats ([@ref43]). According to one review, rats and primates experiencing maternal separation early in life overall display heightened CRF, but diminished ACTH and glucocorticoid levels; in primates, these levels are initially elevated during development, suggesting that the timing of when measurements are obtained may be an important moderating factor ([@ref60]). On the whole, the animal literature mostly supports the conclusion that animal models of ELS produce later increases in SNS, HPA axis, and inflammatory markers. The larger degree of consistency across animal studies, compared to the human literature, may have been aided by greater experimental controls, more uniform models of ELS, and homogeneity in the choice of rodent strains.

Early Life Stress and Negative Health Outcomes: The Role of Genetics {#sec5}
====================================================================

Thus far, we have reviewed evidence surrounding ELS and its relationship to the SNS, HPA axis, and immune function, as these may be pathways to negative health later in life. However, ELS may also lead to poorer health outcomes through genetic mechanisms. Indeed, numerous studies have considered the role of genetics, both at the structural level of gene variants and at the level of epigenetic regulation of DNA expression ([@ref30]). Variants of well-known candidate genes may potentially increase susceptibility to stressful environmental conditions, increasing risk for mood and anxiety disorders ([@ref52]). In a seminal longitudinal study of approximately 1,000 individuals, [@ref9] reported a significant interaction between presence of the serotonin-transporter-linked polymorphic region (5-HTTLPR) S allele and life stress history predicting depressive symptoms. Later replication studies produced conflicting results and meta-analyses came to opposite conclusions. One the one hand, one meta-analysis concluded that ELS significantly interacted with presence of the S allele in 5-HTTLPR of *SLC6A4* to predict greater stress sensitivity and risk of depression ([@ref37]). On the other hand, a recent large-scale meta-analysis used harmonized analyses across 31 previously published datasets representing more than 38,000 individuals and failed to identify an interaction between the 5-HTTLPR S allele, life stress, and depression ([@ref16]). The authors concluded that "if an interaction exists in which the S allele of 5-HTTLPR increases risk of depression only in stressed individuals, then it is not broadly generalisable, but must be of modest effect size and only observable in limited situations" (p. 134).

Some other candidate genes included *FKBP5* (a co-chaperone to glucocorticoid receptors as part of the HPA axis leading to stress response regulation and anxiety); the gene encoding the brain-derived neurotrophic factor, *BDNF* (hypothesized role in mood disorders; [@ref52]); and the oxytocin receptor gene, *OXTR* (oxytocin receptors are concentrated in the hypothalamus and dysregulation has been associated with depression and anxiety). For example, [@ref3] identified four SNPs in the *FKBP5* gene interacting with ELS to predict heightened PTSD symptom severity; similar findings were reported by [@ref39], however their results provided robust findings for only the rs1360780 SNP. Presence of the met allele in the val66met *BDNF* polymorphism in conjunction with ELS predicted greater depression and anxiety symptoms, although this was specifically mediated through diminished left prefrontal cortex brain volume and heightened heart rate ([@ref27]). The rs139832701 SNP in *OXTR* interacted with ELS to predict increased stress and depression scores ([@ref51]).

Candidate gene studies have often been criticized for being statistically underpowered, and large-scale replication attempts have not supported previously reported gene-by-environment interactions. In addition to the [@ref16] study, another recent large-state analysis imputed data (i.e., did not genotype directly, but inferred genotype from tagging single nucleotide polymorphisms) from large population-based and case-control samples (Ns ranging from 62,138 to 443,264 across subsamples) for 18 candidate genes (including *SLC6A4* and *BDNF,* but not *FKBP5* or *OXTR*) and also failed to find support for any main effect or interaction predicting depression ([@ref4]). These authors went further than [@ref16], concluding "it is time for depression research to abandon historical candidate gene and candidate gene-by-environment interaction hypotheses" (p. 386).

The criticism of candidate genes raises important concerns about sample size and false positive results. Yet, it is also possible that analyses that are limited to DNA sequence variations and one specific disease outcome miss much of the complexity by which genes, life experience, and health outcomes are interrelated. For example, it is possible that additional mechanisms that have not been considered in the prior literature, such as alternative splicing of the human *SLC6A4* ([@ref5]), contribute to inconsistent findings across study population. The effects of alternative splicing, as well as epigenetic mechanisms (discussed next), would be evident at the level of mRNA or protein expression, for which there are currently only limited datasets available.

The current literature on epigenetics and life stress suggests important mechanisms linking ELS to epigenetic gene regulatory mechanisms, particularly DNA methylation. DNA methylation is the process by which a methyl group binds to, most typically, Cytosin-Guanine (CpG) sites on DNA and regulates its expression (for further information see [@ref50]). Such methylation may be caused by life stress. As early as *in utero*, experiences related to maternal nutrition and health can lead to an increased risk for metabolic dysregulation (e.g., in insulin and leptin) later in life with ELS-induced adaptations in DNA methylation as a proposed pathway to such a relationship ([@ref28]). Therefore, examining how ELS is associated with methylation may provide insight into one pathway toward dysregulation.

Several studies have reported increased DNA methylation in the presence of ELS. First reported in rats in a seminal study by [@ref66], poor maternal care was linked to increased methylation of the glucocorticoid receptor (GR) gene promoter, reduced GR expression in the hippocampus, and increased adult stress reactivity, which could be reversed with administration of the histone deacetylase (HDAC) inhibitor trichostatin A (TSA). A study by [@ref46] extended these findings to humans, showing increased GR methylation and reduced GR mRNA expression in the hippocampus of suicide victims with a history of childhood abuse, compared to suicide victims without childhood abuse and non-suicide controls. In other work, adult participants who had experienced physical abuse as children had higher *SCL6A4* DNA methylation in blood relative to those who had not ([@ref1]). Those with major depressive disorder (MDD) who had experienced ELS also exhibited a greater percentage of average methylation of *SLC6A4* in blood cells compared to those with MDD who had not experienced ELS ([@ref36]). In those with PTSD, the ELS group had a greater proportion of transcripts with methylated CpG sites in blood cells compared to the no ELS group ([@ref47]). Evidence for ELS and methylation exists across species as well. Rats that experienced abusive behavior during development by stressed mothers showed increased DNA methylation of *BDNF* in the prefrontal cortex at exons IV and IX ([@ref62]). Finally, the presence of methylation may be a function of both genotype and the presence of ELS. For instance, [@ref22] found that presence of the S allele in the serotonin-transporter-linked polymorphic region (5-HTTLPR) interacted with ELS to predict greater average methylation of *SCL6A4* in blood samples; however, this did not correspond to downstream mRNA expression, suggesting more than just DNA methylation effects need to be considered. ELS interacted with rs1360780 in *FKBP5* such that presence of the T allele in conjunction with ELS was associated with decreased methylation percentage of intron 7 in blood cells ([@ref39]). This evidence collectively suggests that methylation may represent one pathway to poorer health.

Conclusions and Future Recommendations {#sec6}
======================================

It is now widely accepted that ELS is linked to significant adverse sequelae in adulthood ([@ref23]; [@ref63]). However, this association needs to be better understood in its nuances. For instance, different types of ELS may be differentially associated with health risk; although most forms of ELS are associated with increased risk of psychopathology, surprisingly, this association was weaker for forms of physical neglect ([@ref8]). This may stem from discrepancies in the severity of ELS types or from differences in the response (or lack thereof) to different ELS types. Negative consequences of ELS may be most pronounced when the stress takes on its most severe forms ([@ref9]; [@ref38]), when there are numerous instances of ELS ([@ref34]; [@ref20]; [@ref51]), or in the context of other moderating factors. This includes, but is certainly not limited to, genetic disposition ([@ref52]) and ELS-related epigenetic modifications of genes involved in the stress systems ([@ref30]).

Another consideration is that ELS perhaps does not present a unique threat to underlying physiology relative to other forms of stress. In one area of thought, ELS is unique because it takes place during developmentally sensitive periods, where underlying physiology later in life is particularly vulnerable to stressful experiences ([@ref44]). However, other evidence calls into doubt the singular role of ELS in that some forms of stress have a profound impact regardless of their timing. For example, sexual abuse, whether it occurs early in life or later on in adulthood, has been linked to a host of somatic disorders, including gastrointestinal problems and chronic pain ([@ref57]). Similarly, an increase in stressful life events (regardless of age that the stressors occurred) was associated with increased depression ([@ref61]) and evidence exists that such lifelong stress interacts with the presence of the S allele on 5-HTTLPR to predict increased rates of depression ([@ref9]), although this finding continues to generate debate ([@ref37]; [@ref16]). Further complicating this narrative is the notion that different types of ELS co-occur ([@ref48]). Therefore, the detrimental effects of stress may not be restricted to the early developmental period, but rather might be determined by severity and number of different stressors.

Based on these considerations, we make three recommendations for the field to advance: (1) begin with rigorous operational definitions of ELS, thus making it easier to measure and compare findings across studies. At present, there are numerous methodologies to measure ELS (e.g., questionnaires ([@ref2]), interview methods ([@ref6]), or by asking a social worker or caregiver if previous abuse has occurred), all potentially introducing unique variance that may help explain some of the inconsistent results. Showing correlations between instrument types within the same study (e.g., validating a social worker's report with a high score on a standardized questionnaire by the trauma survivor) may set a gold standard to interpret any findings. (2) Consider ELS in a larger genetic and environmental context. This would span genetic profiles for multiple genes of interest or polygenic risk scores (for further information see [@ref21]), as well as current stressors in the person's life and presence of social support ([@ref33]; [@ref18]). (3) Conduct research in ways that mitigate, reframe, or reverse the consequences of ELS. Teaching children appropriate coping mechanisms and building social networks ([@ref67]) may act as deterrents to these negative outcomes. Likewise, in applying lessons from the animal literature, environmental enrichment (i.e., cognitive stimulation and physical activity) may act as another mechanism to help mitigate negative effects ([@ref26]).

Author Contributions {#sec7}
====================

NF wrote the initial draft. TC revised the initial draft. Both TC and NF conceptualized the material for review.

Conflict of Interest Statement {#sec8}
------------------------------

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

[^1]: Edited by: Rosario Montirosso, Eugenio Medea (IRCCS), Italy

[^2]: Reviewed by: Richard G. Hunter, University of Massachusetts Boston, United States; Eva Unternaehrer, Universität Konstanz, Germany

[^3]: ^†^Present address: Nia Fogelman, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States

[^4]: This article was submitted to Developmental Psychology, a section of the journal Frontiers in Psychology
